Aufgrund eines technischen Fehlers werden die URLs in den elektronischen Formularen nicht korrekt angezeigt. Wir arbeiten an einer Lösung. Vorerst empfehlen wir Ihnen, das Komma oder andere Sonderzeichen, die fälschlicherweise am Ende der URL erscheinen, zu löschen. Bitte entschuldigen Sie die Unannehmlichkeiten.

Lieferungen - 72034-2023
03/02/2023    S25

Norway-Vadsø: Pharmaceutical products

2023/S 025-072034

Voluntary ex ante transparency notice

Supplies

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority/entity

I.1)Name and addresses
Official name: SYKEHUSINNKJØP HF
National registration number: 916879067
Postal address: Postboks 40
Town: VADSØ
NUTS code: NO Norge
Postal code: 9811
Country: Norway
Contact person: Postmottak Sykehusinnkjøp
E-mail: post@sykehusinnkjop.no
Telephone: +47 78950700
Internet address(es):
Main address: https://permalink.mercell.com/194006923.aspx
Address of the buyer profile: http://www.sykehusinnkjop.no/
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Voluntary ex ante transparency notice - FDG for Oslo Universitetssykehus HF

Reference number: 2023/46
II.1.2)Main CPV code
33600000 Pharmaceutical products
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Sykehusinnkjøp HF is managing a Voluntary ex ante transparency notice on behalf of Oslo Universitetssykehus HF [Oslo University Hospital Trust) where the intention is to enter into a framework agreement for the procurement of FDG from GE Healthcare AS. 

II.1.6)Information about lots
This contract is divided into lots: no
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 112 000 000.00 NOK
II.2)Description
II.2.3)Place of performance
NUTS code: NO081 Oslo
II.2.4)Description of the procurement:

Oslo Universitetssykehus HF offers PET/CT examinations, which are the most advanced diagnostic imaging examination methods currently available. In order to implement this examination a radioactive preparation must be procured. Currently there is only one manufacturer in Norway, and due to short shelf-life/half-life this is a product that must be delivered the to the agreed time of use.

Oslo Universitetssykehus HF intends to sign a 2 year contract with GE Healthcare AS for delivery of 18F-2'-fluoro-2'-deoxyglucose (FDG), with option for up to 2 years extension 

II.2.5)Award criteria
II.2.11)Information about options
Options: yes
Description of options:

The contracting authority can extend the framework agreement for up to one (1) year at a time for a maximum of two (2) years, so that the maximum combined contract duration is four (4) years.

II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

It is planned to enter into the framework agreement ten days after announcement.

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below
  • The procurement falls outside the scope of application of the directive
Explanation:

The justification for awarding the contract without a tender contest notice: Based on market surveys there is only one commercial supplier in the EU/EEA market that offers FDG within the given framework. The contracting authority believes that there is a legal basis to sign a contract without a contest in accordance with the procurement regulation §13-4 first section letter b) no. 2. The plan is to sign a framework agreement 10 days after this voluntary ex-ante transparency notice has been published.

IV.1.3)Information about framework agreement
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information

Section V: Award of contract/concession

V.2)Award of contract/concession
V.2.1)Date of contract award decision:
27/01/2023
V.2.2)Information about tenders
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor/concessionaire
Official name: GE Healthcare Norge AS
Town: Oslo
NUTS code: NO Norge
Country: Norway
The contractor/concessionaire will be an SME: no
V.2.4)Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 112 000 000.00 NOK
V.2.5)Information about subcontracting

Section VI: Complementary information

VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: Øst-Finnmark tingrett
Town: Vadsø
Postal code: 9811
Country: Norway
Internet address: https://www.domstol.no/Enkelt-domstol/ost-finnmark-tingrett/
VI.4.2)Body responsible for mediation procedures
Official name: Klagenemda for offentlige anskaffelser
Town: Bergen
Country: Norway
E-mail: post@knse.no
Internet address: www.klagenemdsekretariatet.no
VI.4.4)Service from which information about the review procedure may be obtained
Official name: Sykehusinnkjøp HF
Postal address: Grev Wedels plass 7
Town: Oslo
Postal code: 0151
Country: Norway
E-mail: legemidler@sykehusinnkjop.no
Internet address: www.sykehusinnkjop.no
VI.5)Date of dispatch of this notice:
30/01/2023